Investor Inquiries
Investor Relations Department
Tel: +965 2228 64444 Ext. 6475
Email: ir@mezzan.com
Omar Fouda – Investor Relations Manager
Email: omar.fouda@mezzan.com
General Inquiries
Tel: +965 2228 6444
Email: info@mezzan.com
Business Development
Pharmacovigilance
For any safety concerns, adverse events, or complaints about Mezzan pharmaceutical products, please contact us:
Hotline: 1833335
Email: pv.safety@mezzan.com